Intrinsiqs

Is Eikon Therapeutics, Inc. Common Stock overvalued?

Eikon Therapeutics, Inc. Common Stock (EIKN) — key valuation metrics and fundamentals.

No verdict
Price
$5.98
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$323.7M
Dividend yield
0.0%
Return on equity
-258.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares EIKN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.